On August 10, 2020 OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, reported that Daniel J. O’Connor, President and Chief Executive Officer will present at the BTIG Virtual Biotechnology Conference 2020 on Tuesday, August 11, 2020 (Press release, OncoSec Medical, AUG 10, 2020, View Source [SID1234563288]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The OncoSec presentation will begin at 12:30 PM ET and will available via webcast at View Source

In addition, the Company will be available for virtual one-on-one meetings on August 10th and 11th. Interested parties should register for the conference via View Source